Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Cellular therapy of Epstein-Barr virus (EBV)(+) posttransplantation lymphoproliferative diseases (PTLD) in cord blood transplant (CBT) recipients is limited by lack of donor access and the donor's naive neonatal immune system. We therefore used partially human leukocyte antigen–matched third-pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Barker, Juliet N., Doubrovina, Ekaterina, Sauter, Craig, Jaroscak, Jennifer J., Perales, Miguel A., Doubrovin, Mikhail, Prockop, Susan E., Koehne, Guenther, O'Reilly, Richard J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2010
Témata:
Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012598/
https://ncbi.nlm.nih.gov/pubmed/20826724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-04-281873
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky